Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 1, 1998, Pages 167-173

  Grimm, J W ^a   Kruzich, P J ^a   See, R E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Glutamate; Haloperidol; Motor cortex; NMDA; Oral movements; Tardive dyskinesia

Indexed keywords

HALOPERIDOL DECANOATE; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUXISM; CONTROLLED STUDY; FEMALE; GROOMING; INTRAMUSCULAR DRUG ADMINISTRATION; LOCOMOTION; LONG TERM CARE; MOTOR CORTEX; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; TARDIVE DYSKINESIA; TREMOR;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; DYSKINESIA, DRUG-INDUCED; FEMALE; HALOPERIDOL; MOTOR ACTIVITY; MOTOR CORTEX; MOUTH; MOVEMENT; N-METHYLASPARTATE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; SESAMUM INDICUM;

EID: 0032077322     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00587-X     Document Type: Article

References (57)

1. Akintunde A., Buxton D. F. Origins and collateralization of corticospinal, corticopontine, corticorubral and corticostriatal tracts. A multiple retrograde fluorescent tracing study Brain Res. 586:1992;208-218.
2. Berretta N., Jones R. S. G. Tonic facilitation of glutamate release by presynaptic N-Methyl-D-Aspartate autoreceptors in the entorhinal cortex. Neuroscience. 75:1996;339-344.
3. Bordi F., Carr K. D., Meller E. Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens. Brain Res. 489:1989;205-215.
4. 2) receptors. A study of the actions of dopamine on cortico-striatal transmission Neuroscience. 10:1983;349-355.
5. Bures J., Bracha V. The control of movements by the motor cortex. Kolb B., Tees R. C., Neisewander J. L., Lucki I., McGonigle P. The cerebral cortex of the rat. 1990;213-238 MIT Press, Cambridge.
6. Cicirata F., Angaut P., Cioni M., Serapide M. F., Papale A. Functional organization of thalamic projections to the motor cortex. An anatomical and electrophysiological study in the rat. Neuroscience. 19:1986;81-99.
7. Conti F., Minelli A., Molnar M., Brecha N. C. Cellular localization and laminar distribution of NMDAR1 mRNA in the rat cerebral cortex. J. Comp. Neurol. 343:1994;554-565.
8. 2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience. 39:1990;59-67.
9. Ellenbroek B. A. Treatment of schizophrenia. A clinical and preclinical evaluation of neuroleptic drugs Pharmacol. Ther. 57:1993;1-78.
10. 2 agonist LY171555 on oral movements in rats. Psychopharmacology (Berlin). 96:1988;253-257.
11. Glassman R. B., Glassman H. N. Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic. Implication for models of tardive dyskinesia Psychopharmacology (Berlin). 69:1980;19-25.
12. Glenthøj B. Y. Persistent vacuous chewing in rats following neuroleptic treatment. Relationship to dopaminergic and cholinergic function Psychopharmacology (Berlin). 113:1993;157-166.
13. Glenthøj B. Y. The brain dopaminergic system. Dan. Med. Bull. 42:1995;1-21.
14. Glowinski J., Cheramy A., Romo R., Barbeito L. Presynaptic regulation of dopaminergic transmission in the striatum. Cell. Mol. Neurobiol. 8:1988;7-17.
15. Godukhin O. V., Zharikova A. D., Novoselov V. I. The release of labeled l-glutamic acid from rat neostriatum in vivo following stimulation of frontal cortex. Neuroscience. 5:1980;2151-2154.
16. Gunne L. M., Growdon J., Glaeser B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology (Berlin). 77:1982;134-139.
17. Gunne L. M., Growdon J. H. A model for oral dyskinesia in rats. J. Clin. Psychopharmacol. 2:1982;308-311.
18. Hall R. D., Lindholm E. P. Organization of motor and somatosensory neocortex in the albino rat. Brain Res. 66:1974;23-38.
19. Halperin R., Guerin J. J. Jr., Davis K. L. Chronic administration of three neuroleptics. Effects of behavioral supersensitivity mediated by two different brain regions in the rat Life Sci. 33:1983;585-592.
20. Herrero I., Miras-Portugal M. T., Sánchez-Prieto J. Rapid desensitization of the metabotropic glutamate receptor that facilitates glutamate release in rat cerebrocortical nerve terminals. Eur. J. Neurosci. 6:1994;115-120.
21. Johnson K., Churchill L., Klitenick M. A., Hooks M. S., Kalivas P. W. Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. J. Pharmacol. Exp. Ther. 277:1996;1122-1131.
22. Kelley A. E., Delfs J. M. Excitatory amino acid receptors mediate the orofacial stereotypy elicited by dopaminergic stimulation of the ventrolateral striatum. Neuroscience. 60:1994;85-95.
23. Kelley A. E., Lang C. G., Gauthier A. M. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology (Berlin). 95:1988;556-559.
24. Keyser J. D. Excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia. Clin. Neuropharmacol. 14:1991;562-565.
25. 2 and reuptake sites in rats with vacuous chewing movements. Brain Res. 646:1994;217-222.
26. Kornhuber J., Kornhuber M. E. Presynaptic dopaminergic modulation of cortical input to the striatum. Life Sci. 39:1986;669-674.
27. McGeorge A. J., Gaull R. L. M. The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain. Brain Res. 423:1987;318-324.
28. Meshul C. K., Buckman J. F., Allen C., Riggan J. P., Feller D. J. Activation of cortico-striatal pathway leads to similar morphological changes observed following haloperidol treatment. Synapse. 22:1996;350-361.
29. Meshul C. K., Stallbaumer R. K., Taylor B., Janowsky A. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res. 648:1994;181-195.
30. Muller P., Seeman P. Dopaminergic supersensitivity after neuroleptics. Time-course and specificity Psychopharmacology (Berlin). 60:1978;1-11.
31. Neafsey E. J. The complete ratunculus. Output organization of layer V of the cerebral cortex Kolb B., Tees R. C., Neisewander J. L., Lucki I., McGonigle P. The cerebral cortex of the rat. 1990;197-212 MIT Press, Cambridge.
32. Palmer A. M., Hutson P. H., Lowe S. L., Bowen D. M. Extracellular concentrations of aspartate and glutamate in rat neostriatum following chemical stimulation of frontal cortex. Exp. Brain Res. 75:1989;659-663.
33. Parent A., Hazrati L. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20:1995;91-127.
34. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2:1986;Academic Press, San Diego.
35. Perschak H., Cuénod M. In vivo release of endogenous glutamate and aspartate in the rat striatum during stimulation of the cortex. Neuroscience. 35:1990;283-287.
36. Pisa M. Motor functions of the striatum in the rat. Critical role of the lateral region in tongue and forelimb reaching Neuroscience. 24:1988;453-463.
37. 3H] from rat striatal slices. Brain Res. 157:1978;391-395.
38. Sanderson K. J., Welker W., Shambes G. M. Reevaluation of motor cortex and of sensorimotor overlap in cerebral cortex of albino rats. Brain Res. 292:1984;251-260.
39. Sasamoto K., Zhang G., Iwasaki M. Two types of rhythmical jaw movements evoked by stimulation of the rat cortex. Jpn. J. Oral Biol. 32:1990;57-68.
40. Scheel-Kruger J., Arnt J. New aspects on the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia. Casey D. E. Dyskinesia - Research and treatment. 1985;46-57 Springer, Heidelberg.
41. See R. E., Ellison G. Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats. Psychopharmacology (Berlin). 100:1990;404-412.
42. 1 receptors. Life Sci. 44:1989;229-236.
43. See R. E., Levin E. D., Ellison G. E. Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. Psychopharmacology (Berlin). 94:1988;421-427.
44. See R. E., Chapman M. A. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. Eur. J. Pharmacol. 263:1994;269-276.
45. See R. E., Chapman M. A. The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals. Crit. Rev. Neurobiol. 8:1994;85-124.
46. See R. E., Chapman M. A., Meshul C. K. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse. 12:1992;147-154.
47. See R. E., Chapman M. A., Murray C. E., Aravagiri M. Regional differences in chronic neuroleptic effects on extracellular dopamine activity. Brain Res. Bull. 29:1992;473-478.
48. See R. E., Lynch A. M. Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex. Neuroreport. 6:1995;1795-1798.
49. See R. E., Lynch A. M. Duration-dependent increase in striatal glutamate following prolonged fluphenazine administration in rats. Eur. J. Pharmacol. 308:1996;279-282.
50. 1 binding site correlates of haloperidol-induced oral dyskinesias in rat. Exp. Neurol. 127:1994;62-69.
51. Sutor B., Hablitz J. J. EPSPs in rat neocortical neurons in vitro II. Involvement of N-Methyl-D-Aspartate receptors in the generation of EPSP's. J. Neurophysiol. 61:1989;621-634.
52. Taber M. T., Fibiger H. C. Electrical stimulation of the medial prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology. 9:1993;271-275.
53. Tarsy D., Baldessarini R. J. Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interferes with the synaptic function of catecholamines. Neuropharmacology. 13:1974;927-940.
54. Ulas J., Nguyen L., Cotman C. W. Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. Neuroreport. 4:1993;1049-1051.
55. Waddington J. L., Cross A. J., Gamble S. J., Bourne R. C. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science. 220:1983;530-532.
56. Yamamoto B. K., Cooperman M. A. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14:1994;4159-4166.
57. Yamamoto B. K., Davy S. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem. 58:1992;1736-1742.